BCA
DCPH

Berman Capital Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Berman Capital Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Buy
+38
New +$1.21K ﹤0.01% 2012
2020
Q3 		– Sell
-29
Closed -$1K – 1814
2020
Q2 		$1K Buy
+29
New +$1.55K ﹤0.01% 1541

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Berman Capital Advisors's DCPH Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2021: 38 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2012 among its holdings. This is a return to the name: Berman Capital Advisors previously reported a position in DCPH as recently as Q2 2020.

Berman Capital Advisors first reported a position in DCPH in Q2 2020 and has held it in 2 quarters since. 161 funds tracked by Wall St. Rank hold DCPH as of Q3 2021.

  • Berman Capital Advisors held 38 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $1K as of Q3 2021.
  • Deciphera Pharmaceuticals, Inc. Common Stock was a new Berman Capital Advisors position in Q3 2021.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #2012 holding.
  • Berman Capital Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and has held it in 2 quarters since.
  • 161 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.